Perioperative use of NSAIDs and the risk of short-term endoscopic recurrence in Crohn’s disease patients: A retrospective cohort study

    • Papadakis K.A.
    • Tabibzadeh S.

    Diagnosis and misdiagnosis of inflammatory bowel disease.

    Gastrointest Endosc Clin N Am. 2002; 12: 433-449https://doi.org/10.1016/S1052-5157(02)00005-3

    • Podolsky D.K.

    Inflammatory bowel disease.

    N Engl J Med. 2002; 347: 417-429https://doi.org/10.1056/NEJMra020831

    • Toh J.W.T.
    • Wang N.
    • Young C.J.
    • et al.

    Major abdominal and perianal surgery in Crohn’s disease: long-term follow-up of Australian patients with Crohn’s disease.

    Dis Colon Rectum. 2018; 61: 67-76https://doi.org/10.1097/DCR.0000000000000975

    • de Buck van Overstraeten A.
    • Eshuis E.J.
    • Vermeire S.
    • et al.

    Short- and medium-term outcomes following primary ileocaecal resection for Crohn’s disease in two specialist centres.

    Br J Surg. 2017; 104: 1713-1722https://doi.org/10.1002/bjs.10595

    • Rutgeerts P.
    • Geboes K.
    • Vantrappen G.
    • et al.

    Predictability of the postoperative course of Crohn’s disease.

    Gastroenterology. 1990; 99: 956-963https://doi.org/10.1016/0016-5085(90)90613-6

    • De Cruz P.
    • Kamm M.A.
    • Hamilton A.L.
    • et al.

    Crohn’s disease management after intestinal resection: a randomised trial.

    Lancet. 2015; 385: 1406-1417https://doi.org/10.1016/S0140-6736(14)61908-5

    • Cryer B.

    NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality.

    Am J Gastroenterol. 2005; 100: 1694-1695https://doi.org/10.1111/j.1572-0241.2005.50565.x

    • Wolfe M.M.
    • Lichtenstein D.R.
    • Singh G.

    Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

    N Engl J Med. 1999; 340: 1888-1899https://doi.org/10.1056/NEJM199906173402407

    • Cashman J.N.

    The mechanisms of action of NSAIDs in analgesia.

    in: Drugs. vol. 52. Springer International Publishing,
    1996: 13-23https://doi.org/10.2165/00003495-199600525-00004

    • Sostres C.
    • Gargallo C.J.
    • Arroyo M.T.
    • et al.

    Adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.

    Best Pract Res Clin Gastroenterol. 2010; 24: 121-132https://doi.org/10.1016/j.bpg.2009.11.005

    • Takeuchi K.
    • Smale S.
    • Premchand P.
    • et al.

    Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.

    Clin Gastroenterol Hepatol. 2006; 4: 196-202https://doi.org/10.1016/S1542-3565(05)00980-8

    • Guslandi M.

    Exacerbation of inflammatory bowel disease by nonsterioidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?.

    World J Gastroenterol. 2006; 12: 1509-1510https://doi.org/10.3748/wjg.v12.i10.1509

    • Wallace J.L.

    Prostaglandin biology in inflammatory bowel disease.

    Gastroenterol Clin North Am. 2001; 30: 971-980https://doi.org/10.1016/S0889-8553(05)70223-5

    • Meyer A.M.
    • Ramzan N.N.
    • Heigh R.I.
    • et al.

    Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs.

    Dig Dis Sci. 2006; 51: 168-172https://doi.org/10.1007/s10620-006-3103-5

    • Maiden L.
    • Thjodleifsson B.
    • Theodors A.
    • et al.

    A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.

    Gastroenterology. 2005; 128: 1172-1178https://doi.org/10.1053/j.gastro.2005.03.020

    • Tanaka K.-I.
    • Suemasu S.
    • Ishihara T.
    • et al.

    Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for nonsteroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.

    Eur J Pharmacol. 2009; 603: 120-132https://doi.org/10.1016/j.ejphar.2008.11.058

    • Tsubouchi R.
    • Hayashi S.
    • Aoi Y.
    • et al.

    Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.

    Digestion. 2007; 74: 91-100https://doi.org/10.1159/000097657

    • Bonner G.F.
    • Fakhri A.
    • Vennamanemi S.R.

    A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease.

    Inflamm Bowel Dis. 2004; 10: 751-757https://doi.org/10.1097/00054725-200411000-00009

    • El Miedany Y.
    • Youssef S.
    • Ahmed I.
    • et al.

    The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases.

    Am J Gastroenterol. 2006; 101: 311-317https://doi.org/10.1111/j.1572-0241.2006.00384.x

    • Sandborn W.J.
    • Stenson W.F.
    • Brynskov J.
    • et al.

    Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.

    Clin Gastroenterol Hepatol. 2006; 4: 203-211https://doi.org/10.1016/j.cgh.2005.12.002

    • Renna S.
    • Cammà C.
    • Modesto I.
    • et al.

    Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn’s disease.

    Gastroenterology. 2008; 135: 1500-1509https://doi.org/10.1053/j.gastro.2008.07.066

    • Hawkins A.T.
    • McEvoy M.D.
    • Wanderer J.P.
    • et al.

    Ketorolac use and anastomotic leak in elective colorectal surgery: a detailed analysis.

    in: Diseases of the Colon and Rectum. vol. 61. Lippincott Williams and Wilkins,
    2018: 1426-1434https://doi.org/10.1097/DCR.0000000000001244

    • Cottone M.
    • Orlando A.
    • Modesto I.

    Postoperative maintenance therapy for inflammatory bowel disease.

    Curr Opin Gastroenterol. 2006; 22: 377-381https://doi.org/10.1097/01.mog.0000231811.95525.7c

    • Buisson A.
    • Chevaux J.B.
    • Allen P.B.
    • et al.

    Review article: the natural history of postoperative Crohn’s disease recurrence.

    Aliment Pharmacol Ther. 2012; 35: 625-633https://doi.org/10.1111/j.1365-2036.2012.05002.x

    • De Cruz P.
    • Kamm M.A.
    • Prideaux L.
    • et al.

    Postoperative recurrent luminal Crohn’s disease: a systematic review.

    Inflamm Bowel Dis. 2012; https://doi.org/10.1002/ibd.21825

    • D’Haens G.R.
    • Vermeire S.
    • Van Assche G.
    • et al.

    Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial.

    Gastroenterology. 2008; 135: 1123-1129https://doi.org/10.1053/j.gastro.2008.07.010

    • Reese G.E.
    • Nanidis T.
    • Borysiewicz C.
    • et al.

    The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies.

    Int J Colorectal Dis. 2008; 23: 1213-1221https://doi.org/10.1007/s00384-008-0542-9

    • To N.
    • Gracie D.J.
    • Ford A.C.

    Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn’s disease.

    Aliment Pharmacol Ther. 2016; 43: 549-561https://doi.org/10.1111/apt.13511

    • Biancone L.
    • Tosti C.
    • Geremia A.
    • et al.

    Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.

    Aliment Pharmacol Ther. 2004; 19: 755-764https://doi.org/10.1111/j.1365-2036.2004.01907.x

    • Bonner G.F.

    Exacerbation of inflammatory bowel disease associated with use of celecoxib.

    Am J Gastroenterol. 2001; 96: 1306-1308https://doi.org/10.1111/j.1572-0241.2001.03730.x

    • Moninuola O.O.
    • Milligan W.
    • Lochhead P.
    • et al.

    Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn’s disease and ulcerative colitis exacerbation.

    Aliment Pharmacol Ther. 2018; 47: 1428-1439https://doi.org/10.1111/apt.14606

    • Kono T.
    • Fichera A.
    • Maeda K.
    • et al.

    Kono-S anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn’s disease: an international multicenter study.

    J Gastrointest Surg. 2016; 20: 783-790https://doi.org/10.1007/s11605-015-3061-3

    • Alshantti A.
    • Hind D.
    • Hancock L.
    • Brown S.R.

    The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn’s disease: a systematic review.

    Colorectal Dis. 2021; 23: 7-17https://doi.org/10.1111/codi.15136

  • Source link

    Back to top button